Details for: HNRNPA0

Gene ID: 10949

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: HNRNPA0

Ensembl ID: ENSG00000177733

Description: heterogeneous nuclear ribonucleoprotein A0

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 82.18
    rCSI 74.22%
    PRS 6.07
  • early lymphoid progenitor CL0000936
    CSI 76.66
    rCSI 67.33%
    PRS 7.71
  • group 3 innate lymphoid cell CL0001071
    CSI 71.95
    rCSI 54.06%
    PRS 7.07
  • peripheral nervous system neuron CL2000032
    CSI 62.84
    rCSI 85.63%
    PRS 6.17
  • pro-B cell CL0000826
    CSI 61.95
    rCSI 51.3%
    PRS 6.89
  • common dendritic progenitor CL0001029
    CSI 60.95
    rCSI 76.5%
    PRS 8.75
  • stem cell CL0000034
    CSI 60.81
    rCSI 58.63%
    PRS 4.21
  • fraction A pre-pro B cell CL0002045
    CSI 60.02
    rCSI 68.71%
    PRS 14.26
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 59.68
    rCSI 68.92%
    PRS 6.13
  • intestinal epithelial cell CL0002563
    CSI 59.03
    rCSI 61.7%
    PRS 7.23
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 58.81
    rCSI 39.62%
    PRS 8.3
  • keratinocyte CL0000312
    CSI 58.61
    rCSI 49.13%
    PRS 8.23
  • common myeloid progenitor CL0000049
    CSI 57.5
    rCSI 46.49%
    PRS 6.75
  • hematopoietic stem cell CL0000037
    CSI 55.47
    rCSI 36.87%
    PRS 8.18
  • mesodermal cell CL0000222
    CSI 52.7
    rCSI 63.26%
    PRS 6.81
  • T-helper 17 cell CL0000899
    CSI 52.35
    rCSI 41.56%
    PRS 12.14
  • enteric smooth muscle cell CL0002504
    CSI 49.28
    rCSI 70.32%
    PRS 7.77
  • transit amplifying cell of colon CL0009011
    CSI 45.7
    rCSI 53.67%
    PRS 8.22
  • radial glial cell CL0000681
    CSI 41.73
    rCSI 57.98%
    PRS 7.12
  • small pre-B-II cell CL0000954
    CSI 40.93
    rCSI 39.36%
    PRS 14.86
  • fallopian tube secretory epithelial cell CL4030006
    CSI 40.33
    rCSI 38.83%
    PRS 7.12
  • epithelial cell of lung CL0000082
    CSI 39.97
    rCSI 33.13%
    PRS 6.54
  • plasmacytoid dendritic cell, human CL0001058
    CSI 39.32
    rCSI 27.45%
    PRS 7.24
  • common lymphoid progenitor CL0000051
    CSI 35.68
    rCSI 47.68%
    PRS 13.16
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 35.17
    rCSI 45.14%
    PRS 6.73
  • granulocyte monocyte progenitor cell CL0000557
    CSI 34.82
    rCSI 30.15%
    PRS 7.64
  • CD4-positive helper T cell CL0000492
    CSI 30.13
    rCSI 22.79%
    PRS 9.56
  • ciliated epithelial cell CL0000067
    CSI 28.97
    rCSI 25.48%
    PRS 4.96
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 27.94
    rCSI 55.7%
    PRS 11.77
  • large pre-B-II cell CL0000957
    CSI 27.08
    rCSI 77.3%
    PRS 12.24
  • double negative thymocyte CL0002489
    CSI 26.82
    rCSI 18.65%
    PRS 8.04
  • mesenchymal cell CL0008019
    CSI 26.21
    rCSI 66.56%
    PRS 7
  • intestine goblet cell CL0019031
    CSI 25.26
    rCSI 22.42%
    PRS 6.87
  • unswitched memory B cell CL0000970
    CSI 24.29
    rCSI 20.44%
    PRS 11.44
  • promyelocyte CL0000836
    CSI 24.1
    rCSI 34.75%
    PRS 9.59
  • T-helper 1 cell CL0000545
    CSI 22.58
    rCSI 40.76%
    PRS 20.16
  • colon epithelial cell CL0011108
    CSI 22.44
    rCSI 23.51%
    PRS 6.39
  • forebrain radial glial cell CL0013000
    CSI 22.39
    rCSI 71.85%
    PRS 10.32
  • myofibroblast cell CL0000186
    CSI 22.35
    rCSI 30.96%
    PRS 9.91
  • enteroendocrine cell CL0000164
    CSI 22.26
    rCSI 30.42%
    PRS 7.61
  • neural crest cell CL0011012
    CSI 21.3
    rCSI 16.83%
    PRS 4.73
  • mature B cell CL0000785
    CSI 21.19
    rCSI 18.42%
    PRS 8.47
  • stromal cell of ovary CL0002132
    CSI 21.11
    rCSI 58.01%
    PRS 11.4
  • respiratory suprabasal cell CL4033048
    CSI 20.77
    rCSI 26.64%
    PRS 7.93
  • thymocyte CL0000893
    CSI 20.64
    rCSI 73.35%
    PRS 22.25
  • naive thymus-derived CD8-positive, alpha-beta T cell CL0000900
    CSI 20.61
    rCSI 14.47%
    PRS 19.64
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 20
    rCSI 18.49%
    PRS 12.58
  • conventional dendritic cell CL0000990
    CSI 19.16
    rCSI 15.99%
    PRS 21.84
  • late pro-B cell CL0002048
    CSI 18.85
    rCSI 47.23%
    PRS 22.25
  • precursor B cell CL0000817
    CSI 18.62
    rCSI 16.31%
    PRS 9.23
  • luminal epithelial cell of mammary gland CL0002326
    CSI 18.29
    rCSI 33.23%
    PRS 10.5
  • T follicular helper cell CL0002038
    CSI 18.2
    rCSI 13.62%
    PRS 11.23
  • promonocyte CL0000559
    CSI 17.85
    rCSI 30.58%
    PRS 9.22
  • granulocyte CL0000094
    CSI 17.83
    rCSI 27.24%
    PRS 8.63
  • interstitial cell of Cajal CL0002088
    CSI 17.61
    rCSI 22.41%
    PRS 7.96
  • transit amplifying cell CL0009010
    CSI 17.39
    rCSI 26.6%
    PRS 11.23
  • naive B cell CL0000788
    CSI 17.3
    rCSI 14.84%
    PRS 15.52
  • basal cell of prostate epithelium CL0002341
    CSI 17.19
    rCSI 49.73%
    PRS 15.53
  • mammary gland epithelial cell CL0002327
    CSI 16.93
    rCSI 59.39%
    PRS 12.57
  • memory B cell CL0000787
    CSI 16.66
    rCSI 16.45%
    PRS 29.04
  • cerebral cortex GABAergic interneuron CL0010011
    CSI 15.69
    rCSI 46.3%
    PRS 8.64
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 15.67
    rCSI 18.98%
    PRS 9.94
  • progenitor cell CL0011026
    CSI 15.64
    rCSI 33.27%
    PRS 12.9
  • epithelial cell CL0000066
    CSI 15.51
    rCSI 23.83%
    PRS 9.89
  • colon goblet cell CL0009039
    CSI 15.12
    rCSI 35.95%
    PRS 10.35
  • class switched memory B cell CL0000972
    CSI 14.95
    rCSI 11.16%
    PRS 11.64
  • extravillous trophoblast CL0008036
    CSI 14.94
    rCSI 18.48%
    PRS 6.02
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 14.26
    rCSI 73.62%
    PRS 13.8
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 13.47
    rCSI 10.38%
    PRS 6.21
  • natural T-regulatory cell CL0000903
    CSI 13.35
    rCSI 25.29%
    PRS 19.59
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 13.32
    rCSI 13.58%
    PRS 9.87
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 13
    rCSI 22.23%
    PRS 14.8
  • tendon cell CL0000388
    CSI 12.74
    rCSI 33.1%
    PRS 20.78
  • P/D1 enteroendocrine cell CL0002268
    CSI 12.69
    rCSI 69.11%
    PRS 17.48
  • bronchus fibroblast of lung CL2000093
    CSI 12.66
    rCSI 10.29%
    PRS 7.33
  • microcirculation associated smooth muscle cell CL0008035
    CSI 12.51
    rCSI 36.21%
    PRS 7.8
  • plasmacytoid dendritic cell CL0000784
    CSI 12.26
    rCSI 12.42%
    PRS 41.33
  • basophil mast progenitor cell CL0002028
    CSI 12.25
    rCSI 65.35%
    PRS 25.11
  • melanocyte CL0000148
    CSI 12.22
    rCSI 9.05%
    PRS 6.28
  • transitional stage B cell CL0000818
    CSI 12.22
    rCSI 40%
    PRS 20.72
  • paneth cell CL0000510
    CSI 12.21
    rCSI 18.03%
    PRS 10.87
  • naive thymus-derived CD4-positive, alpha-beta T cell CL0000895
    CSI 12.07
    rCSI 15.17%
    PRS 34.55
  • pancreatic D cell CL0000173
    CSI 12.04
    rCSI 11.84%
    PRS 7.44
  • perivascular cell CL4033054
    CSI 11.8
    rCSI 16.13%
    PRS 7.81
  • CD16-negative, CD56-bright natural killer cell, human CL0000938
    CSI 11.66
    rCSI 8.74%
    PRS 20.3
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 11.38
    rCSI 44.28%
    PRS 11.39
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 11.36
    rCSI 6.71%
    PRS 9.53
  • Mueller cell CL0000636
    CSI 11.04
    rCSI 25.19%
    PRS 6.24
  • mucosal invariant T cell CL0000940
    CSI 11.03
    rCSI 8.92%
    PRS 13.91
  • placental villous trophoblast CL2000060
    CSI 10.99
    rCSI 16.98%
    PRS 6.45
  • myeloid leukocyte CL0000766
    CSI 10.97
    rCSI 10.12%
    PRS 6.97
  • CD8-positive, alpha-beta memory T cell CL0000909
    CSI 10.94
    rCSI 11.43%
    PRS 21.67
  • eosinophil CL0000771
    CSI 10.85
    rCSI 71.17%
    PRS 18.24
  • skin fibroblast CL0002620
    CSI 10.67
    rCSI 9.19%
    PRS 11.39
  • naive T cell CL0000898
    CSI 10.34
    rCSI 7.2%
    PRS 9.93
  • plasmablast CL0000980
    CSI 10.32
    rCSI 8.12%
    PRS 8.18
  • respiratory basal cell CL0002633
    CSI 10.31
    rCSI 10.68%
    PRS 8.08
  • group 2 innate lymphoid cell CL0001069
    CSI 10.31
    rCSI 55.77%
    PRS 24.21
  • multi-ciliated epithelial cell CL0005012
    CSI 10.3
    rCSI 10.28%
    PRS 5.9
  • immature B cell CL0000816
    CSI 10.3
    rCSI 7.65%
    PRS 10.3
  • ciliated cell CL0000064
    CSI -10.2
    rCSI -16.5%
    PRS 7.0%
  • squamous epithelial cell CL0000076
    CSI -9.9
    rCSI -23.6%
    PRS 9.2%
  • choroid plexus epithelial cell CL0000706
    CSI -7.5
    rCSI -12.2%
    PRS 5.3%
  • regular ventricular cardiac myocyte CL0002131
    CSI -6.2
    rCSI -38.9%
    PRS 5.6%
  • alveolar macrophage CL0000583
    CSI -5.9
    rCSI -9.7%
    PRS 8.1%
  • tuft cell of colon CL0009041
    CSI -5.6
    rCSI -13.1%
    PRS 16.0%
  • astrocyte of the cerebral cortex CL0002605
    CSI -5.3
    rCSI -11.9%
    PRS 4.2%
  • tracheal goblet cell CL1000329
    CSI -4.7
    rCSI -10.2%
    PRS 14.1%
  • CD14-positive monocyte CL0001054
    CSI -4.0
    rCSI -5.0%
    PRS 10.0%
  • platelet CL0000233
    CSI -3.3
    rCSI -13.6%
    PRS 18.1%
  • lung pericyte CL0009089
    CSI -2.9
    rCSI -7.6%
    PRS 8.2%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI -2.4
    rCSI -2.9%
    PRS 12.0%
  • cerebral cortex neuron CL0010012
    CSI -2.0
    rCSI -8.2%
    PRS 7.6%
  • retinal pigment epithelial cell CL0002586
    CSI -1.8
    rCSI -3.6%
    PRS 7.4%
  • Kupffer cell CL0000091
    CSI -1.8
    rCSI -4.1%
    PRS 6.7%
  • mesenchymal stem cell of adipose tissue CL0002570
    CSI -1.8
    rCSI -9.9%
    PRS 24.0%
  • neural cell CL0002319
    CSI -1.7
    rCSI -6.4%
    PRS 12.5%
  • nasal mucosa goblet cell CL0002480
    CSI -1.4
    rCSI -1.6%
    PRS 10.2%
  • decidual natural killer cell, human CL0002343
    CSI -1.3
    rCSI -13.5%
    PRS 53.3%
  • alpha-beta T cell CL0000789
    CSI -1.2
    rCSI -1.4%
    PRS 10.3%
  • mucus secreting cell CL0000319
    CSI -1.0
    rCSI -1.6%
    PRS 8.9%
  • Schwann cell CL0002573
    CSI -0.9
    rCSI -2.6%
    PRS 8.9%
  • corticothalamic-projecting glutamatergic cortical neuron CL4023013
    CSI -0.8
    rCSI -5.0%
    PRS 4.3%
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI -0.8
    rCSI -2.9%
    PRS 4.2%
  • L6b glutamatergic cortical neuron CL4023038
    CSI -0.4
    rCSI -1.2%
    PRS 4.3%
  • sncg GABAergic cortical interneuron CL4023015
    CSI -0.4
    rCSI -0.6%
    PRS 4.5%
  • renal beta-intercalated cell CL0002201
    CSI -0.3
    rCSI -0.7%
    PRS 8.6%
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI -0.3
    rCSI -0.8%
    PRS 9.9%
  • ventricular cardiac muscle cell CL2000046
    CSI -0.2
    rCSI -0.6%
    PRS 29.8%
  • uterine smooth muscle cell CL0002601
    CSI -0.2
    rCSI -1.1%
    PRS 46.9%
  • skeletal muscle satellite stem cell CL0008011
    CSI 0.1
    rCSI 0.4%
    PRS 23.8%
  • chandelier pvalb GABAergic cortical interneuron CL4023036
    CSI 0.1
    rCSI 0.3%
    PRS 4.7%
  • epithelial cell of esophagus CL0002252
    CSI 0.1
    rCSI 1.0%
    PRS 27.3%
  • non-classical monocyte CL0000875
    CSI 0.1
    rCSI 0.2%
    PRS 22.7%
  • acinar cell of salivary gland CL0002623
    CSI 0.1
    rCSI 3.0%
    PRS 11.2%
  • IgM plasma cell CL0000986
    CSI 0.2
    rCSI 0.7%
    PRS 35.8%
  • parietal cell CL0000162
    CSI 0.2
    rCSI 1.6%
    PRS 41.6%
  • retinal ganglion cell CL0000740
    CSI 0.2
    rCSI 0.4%
    PRS 4.9%
  • osteoblast CL0000062
    CSI 0.3
    rCSI 6.7%
    PRS 54.7%
  • L5 extratelencephalic projecting glutamatergic cortical neuron CL4023041
    CSI 0.3
    rCSI 1.1%
    PRS 3.7%
  • pancreatic epsilon cell CL0005019
    CSI 0.3
    rCSI 1.5%
    PRS 17.0%
  • cerebral cortex endothelial cell CL1001602
    CSI 0.3
    rCSI 0.6%
    PRS 5.2%
  • renal intercalated cell CL0005010
    CSI 0.4
    rCSI 3.2%
    PRS 53.1%
  • cord blood hematopoietic stem cell CL2000095
    CSI 0.4
    rCSI 7.4%
    PRS 51.1%
  • brush cell CL0002204
    CSI 0.4
    rCSI 0.8%
    PRS 19.4%
  • midbrain dopaminergic neuron CL2000097
    CSI 0.4
    rCSI 2.5%
    PRS 11.4%
  • enterocyte of epithelium of large intestine CL0002071
    CSI 0.5
    rCSI 2.4%
    PRS 13.1%
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 0.5
    rCSI 0.8%
    PRS 4.0%
  • intraepithelial lymphocyte CL0002496
    CSI 0.5
    rCSI 1.3%
    PRS 31.3%
  • pulmonary capillary endothelial cell CL4028001
    CSI 0.5
    rCSI 1.0%
    PRS 11.1%
  • activated CD4-positive, alpha-beta T cell, human CL0001043
    CSI 0.5
    rCSI 1.3%
    PRS 43.9%
  • cytotoxic T cell CL0000910
    CSI 0.6
    rCSI 3.3%
    PRS 10.4%
  • basal cell of epithelium of trachea CL1000348
    CSI 0.6
    rCSI 4.2%
    PRS 22.2%
  • myeloid dendritic cell, human CL0001057
    CSI 0.6
    rCSI 3.4%
    PRS 22.4%
  • sst GABAergic cortical interneuron CL4023017
    CSI 0.6
    rCSI 0.8%
    PRS 4.3%
  • alternatively activated macrophage CL0000890
    CSI 0.6
    rCSI 0.8%
    PRS 10.6%
  • enterocyte of epithelium of small intestine CL1000334
    CSI 0.7
    rCSI 10.3%
    PRS 17.5%
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 0.7
    rCSI 4.1%
    PRS 16.0%
  • Bergmann glial cell CL0000644
    CSI 0.7
    rCSI 0.9%
    PRS 7.3%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 0.7
    rCSI 3.6%
    PRS 9.0%
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 0.8
    rCSI 1.0%
    PRS 9.6%
  • forebrain neuroblast CL1000042
    CSI 0.8
    rCSI 8.2%
    PRS 67.4%
  • B-2 B cell CL0000822
    CSI 0.8
    rCSI 16.9%
    PRS 40.8%
  • smooth muscle cell of prostate CL1000487
    CSI 0.8
    rCSI 4.9%
    PRS 35.2%
  • enteroendocrine cell of small intestine CL0009006
    CSI 0.9
    rCSI 1.9%
    PRS 10.6%
  • periportal region hepatocyte CL0019026
    CSI 0.9
    rCSI 3.6%
    PRS 10.9%
  • duct epithelial cell CL0000068
    CSI 1.0
    rCSI 1.4%
    PRS 7.3%
  • basophil CL0000767
    CSI 1.0
    rCSI 2.0%
    PRS 14.8%
  • hepatocyte CL0000182
    CSI 1.0
    rCSI 1.8%
    PRS 6.5%
  • syncytiotrophoblast cell CL0000525
    CSI 1.0
    rCSI 2.8%
    PRS 13.9%
  • myelocyte CL0002193
    CSI 1.0
    rCSI 6.5%
    PRS 23.6%
  • tissue-resident macrophage CL0000864
    CSI 1.0
    rCSI 4.9%
    PRS 17.3%
  • regular atrial cardiac myocyte CL0002129
    CSI 1.1
    rCSI 3.6%
    PRS 7.9%
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 1.1
    rCSI 2.7%
    PRS 3.9%
  • VIP GABAergic cortical interneuron CL4023016
    CSI 1.1
    rCSI 1.4%
    PRS 4.0%
  • tracheobronchial smooth muscle cell CL0019019
    CSI 1.1
    rCSI 2.0%
    PRS 9.1%
  • NKp44-negative group 3 innate lymphoid cell, human CL0001080
    CSI 1.2
    rCSI 36.9%
    PRS 65.1%
  • blood vessel smooth muscle cell CL0019018
    CSI 1.2
    rCSI 9.7%
    PRS 7.2%
  • mononuclear phagocyte CL0000113
    CSI 1.2
    rCSI 2.6%
    PRS 7.5%
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 1.2
    rCSI 1.2%
    PRS 10.9%
  • paneth cell of epithelium of small intestine CL1000343
    CSI 1.2
    rCSI 3.4%
    PRS 10.7%
  • follicular dendritic cell CL0000442
    CSI 1.2
    rCSI 19.7%
    PRS 41.9%
  • endothelial cell of vascular tree CL0002139
    CSI 1.3
    rCSI 7.3%
    PRS 14.9%
  • odontoblast CL0000060
    CSI 1.4
    rCSI 30.5%
    PRS 36.6%
  • GABAergic neuron CL0000617
    CSI 1.4
    rCSI 4.7%
    PRS 5.4%
  • cerebellar granule cell CL0001031
    CSI 1.4
    rCSI 2.1%
    PRS 6.7%
  • basal cell of epidermis CL0002187
    CSI 1.5
    rCSI 2.6%
    PRS 8.5%
  • myeloid dendritic cell CL0000782
    CSI 1.5
    rCSI 2.2%
    PRS 10.1%
  • B-1 B cell CL0000819
    CSI 1.5
    rCSI 39.8%
    PRS 37.7%
  • intermediate monocyte CL0002393
    CSI 1.6
    rCSI 2.3%
    PRS 6.8%
  • peptic cell CL0000155
    CSI 1.6
    rCSI 15.7%
    PRS 21.6%
  • lung microvascular endothelial cell CL2000016
    CSI 1.7
    rCSI 32.2%
    PRS 24.4%
  • Hofbauer cell CL3000001
    CSI 1.8
    rCSI 3.4%
    PRS 8.5%
  • Langerhans cell CL0000453
    CSI 1.8
    rCSI 2.8%
    PRS 12.1%
  • inflammatory macrophage CL0000863
    CSI 1.9
    rCSI 3.2%
    PRS 14.2%
  • mature alpha-beta T cell CL0000791
    CSI 1.9
    rCSI 6.8%
    PRS 11.9%
  • lung resident memory CD8-positive, alpha-beta T cell CL4033039
    CSI 1.9
    rCSI 4.9%
    PRS 21.8%
  • neural progenitor cell CL0011020
    CSI 1.9
    rCSI 8.5%
    PRS 6.9%
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 2.0
    rCSI 2.8%
    PRS 14.6%
  • mast cell CL0000097
    CSI 2.0
    rCSI 4.4%
    PRS 37.5%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [HNRNPA0](/details-gene/10949) encodes Heterogeneous Nuclear Ribonucleoprotein A0, a member of the hnRNP family of RNA-binding proteins. This protein plays a fundamental role in post-transcriptional gene regulation, primarily through its involvement in [mRNA processing](/details-gene/GO:0006397) and the stabilization of mRNAs containing AU-rich elements in their 3'-untranslated regions ([GO:0070935](https://www.ebi.ac.uk/QuickGO/term/GO:0070935)). Consistent with its role in core cellular processes, its expression is significant across a wide range of progenitor and actively differentiating cell types, including hematopoietic precursors like [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050)s and [early lymphoid progenitor](/details-cell/CL0000936)s, as well as various [stem cell](/details-cell/CL0000034) populations. Functionally, it is also implicated in the cellular [inflammatory response](/details-gene/GO:0006954), where it can regulate the stability of cytokine mRNAs. ## Cellular Roles and Expression Landscape The expression profile of [HNRNPA0](/details-gene/10949) highlights its importance in cells undergoing proliferation, differentiation, and dynamic gene expression programs. **Overall**, its significance is highest in progenitor populations across multiple lineages. This includes key hematopoietic precursors such as [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050), [early lymphoid progenitor](/details-cell/CL0000936), [pro-B cell](/details-cell/CL0000826), and [common myeloid progenitor](/details-cell/CL0000049), suggesting a foundational role in the development of the blood and immune systems. Its high significance extends to other developmental contexts, with notable expression in [peripheral nervous system neuron](/details-cell/CL2000032)s, [neuroblast (sensu Nematoda and Protostomia)](/details-cell/CL0000338)s, and epithelial cells like [intestinal epithelial cell](/details-cell/CL0002563)s and [keratinocyte](/details-cell/CL0000312)s. Conversely, [HNRNPA0](/details-gene/10949) shows low to negative significance in many terminally differentiated or specialized cell types. This includes cells with highly specialized structural roles, such as [ciliated cell](/details-cell/CL0000064)s, [squamous epithelial cell](/details-cell/CL0000076)s, and [regular ventricular cardiac myocyte](/details-cell/CL0002131)s. Its low significance in several mature immune effector cells, including [alveolar macrophage](/details-cell/CL0000583)s, [CD14-positive monocyte](/details-cell/CL0001054)s, and [CD8-positive, alpha-beta cytotoxic T cell](/details-cell/CL0000794)s, suggests its primary role may be in the developmental stages of immunity rather than in the direct effector functions of these specific mature cells. This pattern delineates [HNRNPA0](/details-gene/10949) as a protein central to developmental plasticity and regulation, rather than the maintenance of a static, terminally differentiated state. ## Pathways and Molecular Function The primary molecular function of [HNRNPA0](/details-gene/10949) is [RNA binding](/details-gene/GO:0003723), specifically binding to [mRNA](/details-gene/GO:0003729) at AU-rich elements within the 3'-UTR ([GO:0035925](https://www.ebi.ac.uk/QuickGO/term/GO:0035925)). This interaction is a key mechanism for its role in [3'-utr-mediated mrna stabilization](/details-gene/GO:0070935) and broader [mRNA processing](/details-gene/GO:0006397). Its localization within the [nucleus](/details-gene/GO:0005634) and [nucleoplasm](/details-gene/GO:0005654) as part of [ribonucleoprotein complex](/details-gene/GO:1990904)es is consistent with these functions. This regulatory activity is crucial for modulating the [inflammatory response](/details-gene/GO:0006954) and the [response to lipopolysaccharide](/details-gene/GO:0032496). Research indicates that phosphorylation of [HNRNPA0](/details-gene/10949) by MAPKAP-K2, a downstream kinase in the p38 MAPK pathway, can be inhibited to prevent its interaction with cytokine mRNAs [Link](https://doi.org/10.1093/emboj/cdf639). This suggests a dynamic, signal-dependent mechanism where [HNRNPA0](/details-gene/10949) activity is switched on to stabilize inflammatory transcripts following cellular stress or pathogenic challenge. Other studies have confirmed its extensive post-translational modification through phosphorylation and SUMOylation, highlighting a complex regulatory landscape governing its function [Link](https://doi.org/10.1021/ac9004309), [Link](https://doi.org/10.1038/nsmb.2890). ## Research Directions The widespread expression of [HNRNPA0](/details-gene/10949) in progenitor cells and its regulated role in inflammation present several avenues for future research. The data suggest that its function is not merely housekeeping but is instead a critical regulatory node in cell fate and stress responses. **Testable Hypotheses:** 1. Given its high significance in diverse hematopoietic progenitors, [HNRNPA0](/details-gene/10949) may function as a critical regulator of hematopoiesis by selectively stabilizing the mRNAs of key lineage-determining transcription factors, thereby controlling the balance between self-renewal and differentiation. 2. The post-translational modification of [HNRNPA0](/details-gene/10949) acts as a molecular switch that alters its mRNA substrate specificity. In response to inflammatory stimuli like LPS, phosphorylation of [HNRNPA0](/details-gene/10949) may increase its affinity for cytokine mRNAs (e.g., TNF, IL6) while decreasing its affinity for mRNAs involved in cell proliferation, thereby coordinating a switch from a "growth" to an "inflammatory" state. 3. In the nervous system, where it is expressed in both precursors ([neuroblast (sensu Nematoda and Protostomia)](/details-cell/CL0000338)) and mature [peripheral nervous system neuron](/details-cell/CL2000032)s, [HNRNPA0](/details-gene/10949) may facilitate local protein synthesis at the [synapse](/details-gene/GO:0045202) by regulating the stability and transport of specific mRNAs crucial for synaptic plasticity and long-term potentiation. **Proposed Experiment:** To test the hypothesis that phosphorylation of [HNRNPA0](/details-gene/10949) alters its mRNA binding profile (Hypothesis 2), one could perform RNA immunoprecipitation followed by sequencing (RIP-seq) in a monocytic cell line. Cells would be treated with LPS to induce an inflammatory state and p38 MAPK activation. RIP-seq using an anti-HNRNPA0 antibody would be performed on both control and LPS-stimulated cells, as well as on cells treated with a p38/MAPKAP-K2 inhibitor prior to LPS stimulation. Comparing the sets of bound mRNAs would reveal which transcripts are specifically bound by [HNRNPA0](/details-gene/10949) in a phosphorylation-dependent manner, directly linking the signaling pathway to its post-transcriptional regulatory function. **Therapeutic Potential:** As an intracellular RNA-binding protein, [HNRNPA0](/details-gene/10949) is a challenging direct drug target. However, its role in stabilizing inflammatory cytokine mRNAs makes it a compelling node for therapeutic intervention in chronic inflammatory diseases or cancers driven by inflammation. The most viable strategy would likely involve the **inhibition** of its activity. This could be achieved indirectly by targeting the upstream kinases, such as p38 or MAPKAP-K2, that are responsible for its activating phosphorylation. Alternatively, nucleic acid-based therapies like antisense oligonucleotides (ASOs) or siRNAs could be developed to reduce the overall expression of [HNRNPA0](/details-gene/10949) in target tissues, thereby dampening aberrant inflammatory responses.

Genular Protein ID: 3115866506

Symbol: ROA0_HUMAN

Name: Heterogeneous nuclear ribonucleoprotein A0

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 7585247

Title: Isolation and characterization of a novel, low abundance hnRNP protein: A0.

PubMed ID: 7585247

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 12456657

Title: Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs.

PubMed ID: 12456657

DOI: 10.1093/emboj/cdf639

PubMed ID: 19413330

Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

PubMed ID: 19413330

DOI: 10.1021/ac9004309

PubMed ID: 20932473

Title: DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization.

PubMed ID: 20932473

DOI: 10.1016/j.molcel.2010.09.018

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 21406692

Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.

PubMed ID: 21406692

DOI: 10.1126/scisignal.2001570

PubMed ID: 22223895

Title: Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.

PubMed ID: 22223895

DOI: 10.1074/mcp.m111.015131

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 24129315

Title: Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.

PubMed ID: 24129315

DOI: 10.1074/mcp.o113.027870

PubMed ID: 25218447

Title: Uncovering global SUMOylation signaling networks in a site-specific manner.

PubMed ID: 25218447

DOI: 10.1038/nsmb.2890

PubMed ID: 28112733

Title: Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.

PubMed ID: 28112733

DOI: 10.1038/nsmb.3366

Sequence Information:

  • Length: 305
  • Mass: 30841
  • Checksum: 9A976A39345AA149
  • Sequence:
  • MENSQLCKLF IGGLNVQTSE SGLRGHFEAF GTLTDCVVVV NPQTKRSRCF GFVTYSNVEE 
    ADAAMAASPH AVDGNTVELK RAVSREDSAR PGAHAKVKKL FVGGLKGDVA EGDLIEHFSQ 
    FGTVEKAEII ADKQSGKKRG FGFVYFQNHD AADKAAVVKF HPIQGHRVEV KKAVPKEDIY 
    SGGGGGGSRS SRGGRGGRGR GGGRDQNGLS KGGGGGYNSY GGYGGGGGGG YNAYGGGGGG 
    SSYGGSDYGN GFGGFGSYSQ HQSSYGPMKS GGGGGGGGSS WGGRSNSGPY RGGYGGGGGY 
    GGSSF